Sr One Capital Management, LP Silverback Therapeutics, Inc. Transaction History
Sr One Capital Management, LP
- $228 Million
- Q2 2024
A detailed history of Sr One Capital Management, LP transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Sr One Capital Management, LP holds 4,012,903 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,012,903
Previous 4,012,903
-0.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SBTX
# of Institutions
131Shares Held
62MCall Options Held
1.37MPut Options Held
83.8K-
Deerfield Management Company, L.P. (Series C) New York, NY11.1MShares$00.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$00.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA9.24MShares$00.0% of portfolio
-
Black Rock Inc. New York, NY4.08MShares$00.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.25MShares$00.0% of portfolio
About Silverback Therapeutics, Inc.
- Ticker SBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,473,800
- Description
- Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...